  {"id":40018,"date":"2017-05-16T11:00:12","date_gmt":"2017-05-16T02:00:12","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=40018"},"modified":"2018-08-10T15:46:36","modified_gmt":"2018-08-10T06:46:36","slug":"veeva-introduces-vault-siteexchange-to-simplify-document-exchange-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/veeva-introduces-vault-siteexchange-to-simplify-document-exchange-in-clinical-trials\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ\u304cVault SiteExchange\u3092\u767a\u8868 \u81e8\u5e8a\u8a66\u9a13\u4e2d\u306e\u6587\u66f8\u306e\u6388\u53d7\u304c\u30b9\u30e0\u30fc\u30ba\u306b"},"content":{"rendered":"<p style=\"text-align: right;\">2017\u5e745\u670816\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084CRO\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u6642\u306b\u304a\u3051\u308b\u60c5\u5831\u4ea4\u63db\u3084\u30a2\u30af\u30bb\u30b9\u3092\u5bb9\u6613\u306b\u3059\u308b\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-siteexchange\/\">³Ô¹Ï±¬ÁÏ Vault SiteExchange<\/a><\/strong>\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault SiteExchange\u306f\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u9593\u306e\u30b9\u30e0\u30fc\u30ba\u306a\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u901a\u3058\u3066\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u53ef\u8996\u6027\u3092\u9ad8\u3081\u3001\u904b\u7528\u52b9\u7387\u3092\u5411\u4e0a\u3059\u308b\u3053\u3068\u3067\u3001\u65b0\u305f\u306a\u6cbb\u7642\u65b9\u6cd5\u306e\u958b\u767a\u3092\u30b9\u30d4\u30fc\u30c9\u30a2\u30c3\u30d7\u3057\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n<p>\u901a\u5e38\u3001\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u3084\u6cbb\u9a13\u4f9d\u983c\u8005\u306f\u7d19\u30d9\u30fc\u30b9\u3067\u306e\u30d7\u30ed\u30bb\u30b9\u3084\u96fb\u5b50\u30e1\u30fc\u30eb\u3092\u5229\u7528\u3057\u306a\u304c\u3089\u624b\u4f5c\u696d\u3067\u6587\u66f8\u3092\u7ba1\u7406\u3057\u3066\u304a\u308a\u3001\u8a66\u9a13\u4e2d\u306e\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u3084\u305d\u306e\u900f\u660e\u6027\u306e\u78ba\u4fdd\u306b\u306f\u9650\u754c\u304c\u3042\u308a\u307e\u3059\u3002\u305d\u306e\u305f\u3081\u306b\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u304c\u9045\u5ef6\u3057\u3001\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u304c\u4eca\u5f8c\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u305f\u3081\u3089\u3046\u3053\u3068\u3082\u5c11\u306a\u304f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ Vault SiteExchange\u306f\u8907\u6570\u306e\u8a66\u9a13\u306b\u307e\u305f\u304c\u308b\u81e8\u5e8a\u8a66\u9a13\u6587\u66f8\u306b\u95a2\u3059\u308b\u30ea\u30af\u30a8\u30b9\u30c8\u3084\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3001\u901a\u77e5\u3001\u30a2\u30e9\u30fc\u30c8\u3092\u4e00\u5143\u7ba1\u7406\u3059\u308b\u3053\u3068\u3067\u9023\u643a\u3092\u5f37\u5316\u3057\u3001\u4f5c\u696d\u52b9\u7387\u3092\u5411\u4e0a\u3055\u305b\u307e\u3059\u3002\u6cbb\u9a13\u4f9d\u983c\u8005\u3084CRO\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306f\u5bb9\u6613\u3067\u4e00\u8cab\u3057\u305f\u30d7\u30ed\u30bb\u30b9\u3092\u6574\u5099\u3059\u308b\u3053\u3068\u3067\u6587\u66f8\u306e\u30b9\u30e0\u30fc\u30ba\u306a\u53d7\u3051\u6e21\u3057\u3084\u30a2\u30af\u30bb\u30b9\u3092\u5b9f\u73fe\u3057\u3001\u7ba1\u7406\u9762\u306e\u8ca0\u62c5\u3082\u8efd\u6e1b\u3067\u304d\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u8907\u6570\u306e\u81e8\u5e8a\u8a66\u9a13\u306b\u307e\u305f\u304c\u308b\u6587\u66f8\u306e\u30ea\u30af\u30a8\u30b9\u30c8\u72b6\u6cc1\u3092\u5b8c\u5168\u306b\u628a\u63e1\u3059\u308b\u3053\u3068\u3082\u53ef\u80fd\u3067\u3059\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ Vault\u306e\u6226\u7565\u3092\u62c5\u5f53\u3059\u308b\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Jennifer Goldsmith\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u6587\u66f8\u3001\u60c5\u5831\u3001\u305d\u3057\u3066\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u679c\u7684\u304b\u3064\u30bf\u30a4\u30e0\u30ea\u30fc\u306b\u7ba1\u7406\u3059\u308b\u3053\u3068\u306f\u81e8\u5e8a\u8a66\u9a13\u3092\u6210\u529f\u3055\u305b\u308b\u4e0a\u3067\u975e\u5e38\u306b\u91cd\u8981\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Vault SiteExchange\u306f\u6cbb\u9a13\u4f9d\u983c\u8005\u3084CRO\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u60c5\u5831\u3092\u4ea4\u63db\u3057\u3001\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3084\u63d0\u4f9b\u3092\u52a0\u901f\u3055\u305b\u308b\u305f\u3081\u306e\u5171\u901a\u306e\u65b9\u6cd5\u3092\u6574\u5099\u3059\u308b\u3053\u3068\u3067\u5927\u304d\u306a\u30ae\u30e3\u30c3\u30d7\u3092\u57cb\u3081\u3066\u3044\u307e\u3059\u300d<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2017\/05\/SiteExchange2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40023\" src=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2017\/05\/SiteExchange2.jpg\" alt=\"\" width=\"400\" height=\"330\" \/><\/a><br \/>\n\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u306f³Ô¹Ï±¬ÁÏ Vault SiteExchange\u3067\u8907\u6570\u306e\u8a66\u9a13\u3092\u4e00\u89a7\u3067\u304d\u308b<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Vault SiteExchange\u306f\u3001\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/\">\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8<\/a><\/strong>\u3068 <strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-operations\/\">\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3<\/a><\/strong>\u3092\u4e00\u5143\u7ba1\u7406\u3059\u308b\u5305\u62ec\u7684\u306a\u30af\u30ea\u30cb\u30ab\u30eb\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-clinical\/\">³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u306b\u542b\u307e\u308c\u308b\u6700\u65b0\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u3059\u3002<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-edc\/\">Vault EDC<\/a><\/strong>\u3001<strong>Vault eSource<\/strong>\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-ctms\/\">Vault CTMS<\/a><\/strong>\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-etmf\/\">Vault eTMF<\/a><\/strong>\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-study-startup\/\">Vault Study Startup<\/a><\/strong>\u306b\u52a0\u3048\u3066³Ô¹Ï±¬ÁÏ Vault SiteExchange\u304c\u767b\u5834\u3057\u3001³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u306b\u306f6\u3064\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u304c\u63c3\u3044\u307e\u3057\u305f\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u306e\u5c0e\u5165\u306b\u3088\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u5168\u822c\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u3084\u30c7\u30fc\u30bf\u3092\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u7ba1\u7406\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>\u307e\u305f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u5404\u793e\u304c\u52a0\u76df\u3059\u308b\u975e\u55b6\u5229\u56e3\u4f53\u3001<strong><a href=\"http:\/\/www.transceleratebiopharmainc.com\/\">TransCelerate BioPharma Inc.<\/a><\/strong>\u3082\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u3068\u6cbb\u9a13\u4f9d\u983c\u8005\u304cShared Investigator Platform\uff08SIP\uff09\u3092\u4ecb\u3057\u3066\u884c\u3046\u6587\u66f8\u306e\u53d7\u3051\u6e21\u3057\u3084\u30a2\u30af\u30bb\u30b9\u3092\u52b9\u7387\u5316\u3059\u308b\u305f\u3081\u3001³Ô¹Ï±¬ÁÏ Vault SiteExchange\u3092\u63a1\u7528\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u3068TransCelerate\u306e\u63d0\u643a\u306b\u3064\u3044\u3066\u306f\u3001\u5225\u306e<strong><a href=\"https:\/\/www.veeva.com\/resources\/transcelerate-selects-veeva-vault-siteexchange\/\">\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u306f\u3001\u4f01\u696d\u5404\u793e\u304c\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u3068\u30b9\u30e0\u30fc\u30ba\u304b\u3064\u30b9\u30d4\u30fc\u30c7\u30a3\u30fc\u306b\u5171\u540c\u4f5c\u696d\u3084\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u304d\u308b\u3088\u3046\u3001\u9769\u65b0\u7684\u306a\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u6d3b\u304b\u3057\u3066\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3068\u306e\u63d0\u643a\u3092\u9032\u3081\u3066\u304d\u307e\u3057\u305f\u3002TransCelerate\u306f\u305d\u306e\u6700\u65b0\u4e8b\u4f8b\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ\u304c\u4e3b\u5c0e\u3059\u308b\u696d\u754c\u3068\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/IndustryCollaborations\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<br \/>\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067500\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<span style=\"color: #ff991c;\"><a style=\"text-decoration: none; font-weight: bold; color: #ff991c;\" href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><\/p>\n<p>This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2017. This is available on the company\u2019s website at\u00a0<a href=\"http:\/\/www.veeva.com\/\">www.veeva.com<\/a>\u00a0under the Investors section and on the SEC\u2019s website at\u00a0<a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2017\u5e745\u670816\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e &nbsp; ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-40018","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40018"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=40018"}],"version-history":[{"count":9,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40018\/revisions"}],"predecessor-version":[{"id":42994,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40018\/revisions\/42994"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=40018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=40018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=40018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}